These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs? Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643 [Abstract] [Full Text] [Related]
6. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs? Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796 [Abstract] [Full Text] [Related]
8. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Rudén C. Environ Health; 2016 Jul 14; 15(1):74. PubMed ID: 27412149 [Abstract] [Full Text] [Related]
9. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs? Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Hengstler J, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Food Chem Toxicol; 2020 Aug 14; 142():111349. PubMed ID: 32360905 [Abstract] [Full Text] [Related]
11. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI. Smith CJ, Perfetti TA, Hayes AW, Berry SC. Regul Toxicol Pharmacol; 2020 Aug 14; 115():104711. PubMed ID: 32598900 [Abstract] [Full Text] [Related]
13. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs? Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Toxicol Lett; 2020 Oct 01; 331():259-264. PubMed ID: 32360654 [No Abstract] [Full Text] [Related]
16. Significance of and Challenges in Regulating Endocrine Disruptors - How Regulators and Industry Can Conquer? Dhiman SK, Dureja H. Endocr Metab Immune Disord Drug Targets; 2020 Oct 01; 20(10):1664-1681. PubMed ID: 32504507 [Abstract] [Full Text] [Related]
19. Penile density and globally used chemicals in Canadian and Greenland polar bears. Sonne C, Dyck M, Rigét FF, Beck Jensen JE, Hyldstrup L, Letcher RJ, Gustavson K, Gilbert MT, Dietz R. Environ Res; 2015 Feb 01; 137():287-91. PubMed ID: 25601730 [Abstract] [Full Text] [Related]
20. Endocrine disrupting chemicals: human exposure and health risks. Yang M, Park MS, Lee HS. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006 Feb 01; 24(2):183-224. PubMed ID: 17114110 [Abstract] [Full Text] [Related] Page: [Next] [New Search]